Physician profile
Samuel Suede
NPI 1164503116
$15,819.87
in general payments reported to CMS, 2019-2025
50 companies · $2,599 in 2025
The $2,599 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,423 · 2020: $1,616 · 2021: $2,302 · 2022: $2,211 · 2023: $2,354 · 2024: $2,314 · 2025: $2,599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,267.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,741.04 | 2019-2025 | |
| Amgen INC. | $1,595.50 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $1,513.36 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $984.53 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $966.08 | 2019-2024 | Watchman Flx, Watchman Access System, Watchman |
| Astrazeneca Pharmaceuticals Lp | $838.50 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Pfizer INC. | $806.82 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $650.71 | 2019-2025 | Jardiance |
| Esperion Therapeutics, INC. | $559.21 | 2020-2025 | Nexletol |
| Amarin Pharma, INC. | $522.75 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $514.60 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $509.32 | 2021-2025 | Verquvo, Capvaxive |
| Abiomed | $495.36 | 2019-2025 | Impella |
| Kowa Pharmaceuticals America, INC. | $421.65 | 2019-2024 | Livalo |
| Abbott Laboratories | $365.65 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Aveir, Jot Dx |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $336.32 | 2025 | Rapiblyk |
| Novo Nordisk INC | $260.98 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Alnylam Pharmaceuticals INC. | $259.04 | 2019-2025 | Amvuttra, Onpattro |
| Sanofi-Aventis U.S. LLC | $225.20 | 2019-2022 | |
| Heartflow, INC. | $206.98 | 2022-2025 | |
| Philips North America LLC | $187.69 | 2022-2025 | Mcot, (Ck4) Mcot |
| W. L. Gore & Associates, INC. | $174.33 | 2021-2022 | |
| Cvrx, INC. | $171.43 | 2022-2025 | Barostim Neo System |
| Medtronic, INC. | $168.43 | 2025 | Symplicity G3 |
| Medicomp INC | $140.09 | 2024-2025 | Telepatch Cardiac Monitor |
| Arbor Pharmaceuticals, INC. | $136.85 | 2019-2021 | |
| Bardy Diagnostics, INC. | $97.03 | 2019-2021 | |
| Lundbeck LLC | $93.52 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.18 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $67.88 | 2023-2024 | Inpefa |
| Regeneron Healthcare Solutions, INC. | $60.61 | 2019-2021 | |
| Preventice Services, LLC | $58.65 | 2020 | |
| Portola Pharmaceuticals, LLC | $57.08 | 2019-2020 | |
| Gilead Sciences, INC. | $56.80 | 2019 | |
| Azurity Pharmaceuticals, INC. | $50.52 | 2023-2024 | Edarbi, Edarbi |
| Actelion Pharmaceuticals US, INC. | $48.96 | 2024-2025 | Opsumit |
| Impulse Dynamics (USA) INC. | $48.66 | 2022-2024 | Optimizer |
| Baxter Healthcare | $48.40 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Kiniksa Pharmaceuticals International, Plc | $48.38 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, Ltd. | $45.00 | 2023 | Arcalyst |
| Bridgebio Pharma, INC. | $32.97 | 2025 | Attruby |
| Seqirus USA INC | $30.84 | 2022-2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Chiesi USA, INC. | $29.24 | 2019 | |
| Irhythm Technologies, INC. | $28.48 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Edwards Lifesciences Corporation | $17.45 | 2019 | |
| Atricure, INC. | $16.75 | 2022 | |
| Glaxosmithkline, LLC. | $14.50 | 2020 | |
| Sun Pharmaceutical Industries INC. | $13.63 | 2022 | |
| Medtronic Vascular, INC. | $11.99 | 2020 | |
| Allergan, INC. | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Suede listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.